Transthyretin Amyloidosis (ATTR)

Canadian Association for Population Therapeutics (CAPT) 2025

Congress Details

September 22-23, 2025

Toronto, ON, Canada

The material below is provided to support scientific exchange and pertains to select congress resources. Any content about investigational therapeutics or investigational uses of locally approved products does not establish the safety or efficacy of these therapeutics or uses, and there is no guarantee of local regulatory approval.

All congress materials are copyrighted by Alnylam. Permission is required to copy or distribute.

For questions beyond a product’s authorized indications or for information not available here, please contact Alnylam Medical Information.